OncoTherapy Science Inc. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY19.9 |
Market Cap |
JPY17.48 B |
Shares Outstanding |
154.99 M |
Public Float |
111.76 M |
Address |
Kanagawa Science Park R&D D Bldg. Kawasaki Kanagawa 213 Japan |
Employees | - |
Website | http://www.oncotherapy.co.jp |
Updated | 07/08/2019 |
OncoTherapy Science, Inc. engages in the research and development of pharmaceutical products. It focuses its research on cancer-related cells and genes, and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine and nucleic acid drugs. The company was founded on April 6, 2001 and is headquartered in Kawasaki, Japan. |